Literature DB >> 3537147

Stimulation of muscle protein degradation by murine and human epidermal cytokines: relationship to thermal injury.

D N Sauder, J Semple, D Truscott, B George, G H Clowes.   

Abstract

Accelerated muscle proteolysis is a characteristic of systemic reaction following trauma, sepsis, or extensive thermal injury. The factors involved in this accelerated muscle breakdown have not been fully described. However, recently leukocytic pyrogen or interleukin 1 (IL-1) have been implicated in the induction of muscle protein degradation in septicemia or trauma. The epidermal cytokine epidermal cell-derived thymocyte activating factor (ETAF) is biochemically and functionally similar to IL-1. Injury to skin can augment ETAF activity. Using a murine model, we found that thermal injury can significantly enhance ETAF/IL-1 activity in a dose-dependent fashion. In addition, ETAF can cause net muscle protein breakdown in vitro. Thus, increased amounts of ETAF produced by thermally injured skin may contribute to the accelerated muscle breakdown in extensive thermal injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537147     DOI: 10.1111/1523-1747.ep12456681

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Diagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical care.

Authors:  Tjasa Hranjec; Brian R Swenson; Lesly A Dossett; Rosemarie Metzger; Tanya R Flohr; Kimberley A Popovsky; Hugo J Bonatti; Addison K May; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

2.  Disruption of interleukin-1 signaling improves the quality of wound healing.

Authors:  Alan A Thomay; Jean M Daley; Edmond Sabo; Patrick J Worth; Leslie J Shelton; Mark W Harty; Jonathan S Reichner; Jorge E Albina
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

Review 3.  Interleukin-1 and the response to injury.

Authors:  E Kaplan; C A Dinarello; J A Gelfand
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.